Search research articles
Contact Us
Filters
Showing results (231-240 of 259) with videos related to
Page
of 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2019
FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia
Kelly J Norsworthy, Kunthel By, Sriram Subramaniam, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
April 7, 2023
Feasibility of an online consensus approach for the diagnosis of cognitive impairment and dementia in rural South Africa
Darina T Bassil, Meagan T Farrell, Albert Weerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 30, 2019
FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation
Kelly J Norsworthy, Lola Luo, Vicky Hsu, et al.
Global Advances in Integrative Medicine and Health
|
September 2, 2025
Acupuncture Treatment for Individuals With Myasthenia Gravis - A Pilot Randomized Clinical Trial
Amanda A Herrmann, Ella A Chrenka, Lap Pui Chung, et al.
JCI Insight
|
November 21, 2023
Lactate- and immunomagnetic-purified hiPSC-derived cardiomyocytes generate comparable engineered cardiac tissue constructs
Kalina J Rossler, Willem J de Lange, Morgan W Mann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2020
Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis
Kelly J Norsworthy, Flora Mulkey, Emma C Scott, et al.
Biorxiv : the Preprint Server for Biology
|
May 19, 2023
Lactate and Immunomagnetic-purified iPSC-derived Cardiomyocytes Generate Comparable Engineered Cardiac Tissue Constructs
Kalina J Rossler, Willem J de Lange, Morgan W Mann, et al.
The Oncologist
|
December 7, 2013
U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemia
Firoozeh Alvandi, Virginia E Kwitkowski, Chia-Wen Ko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2018
FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia
Emily Y Jen, Chia-Wen Ko, Jee Eun Lee, et al.
Circulation Research
|
October 2, 2019
An Unbiased Proteomics Method to Assess the Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes
Wenxuan Cai, Jianhua Zhang, Willem J de Lange, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 259) with videos related to
Sort By:
Page
of 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2019
FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia
Kelly J Norsworthy, Kunthel By, Sriram Subramaniam, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
April 7, 2023
Feasibility of an online consensus approach for the diagnosis of cognitive impairment and dementia in rural South Africa
Darina T Bassil, Meagan T Farrell, Albert Weerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 30, 2019
FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation
Kelly J Norsworthy, Lola Luo, Vicky Hsu, et al.
Global Advances in Integrative Medicine and Health
|
September 2, 2025
Acupuncture Treatment for Individuals With Myasthenia Gravis - A Pilot Randomized Clinical Trial
Amanda A Herrmann, Ella A Chrenka, Lap Pui Chung, et al.
JCI Insight
|
November 21, 2023
Lactate- and immunomagnetic-purified hiPSC-derived cardiomyocytes generate comparable engineered cardiac tissue constructs
Kalina J Rossler, Willem J de Lange, Morgan W Mann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2020
Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis
Kelly J Norsworthy, Flora Mulkey, Emma C Scott, et al.
Biorxiv : the Preprint Server for Biology
|
May 19, 2023
Lactate and Immunomagnetic-purified iPSC-derived Cardiomyocytes Generate Comparable Engineered Cardiac Tissue Constructs
Kalina J Rossler, Willem J de Lange, Morgan W Mann, et al.
The Oncologist
|
December 7, 2013
U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemia
Firoozeh Alvandi, Virginia E Kwitkowski, Chia-Wen Ko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2018
FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia
Emily Y Jen, Chia-Wen Ko, Jee Eun Lee, et al.
Circulation Research
|
October 2, 2019
An Unbiased Proteomics Method to Assess the Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes
Wenxuan Cai, Jianhua Zhang, Willem J de Lange, et al.
Page
of 26